These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16368297)

  • 1. An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure.
    Eshaghian S; Horwich TB; Fonarow GC
    Am Heart J; 2006 Jan; 151(1):91. PubMed ID: 16368297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure).
    Echouffo-Tcheugui JB; Sheng S; DeVore AD; Matsouaka RA; Hernandez AF; Yancy CW; Heidenreich PA; Bhatt DL; Fonarow GC
    Am J Cardiol; 2019 Feb; 123(4):618-626. PubMed ID: 30553509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher hemoglobin A1c levels are associated with impaired left ventricular diastolic function and higher incidence of adverse cardiac events in patients with nonischemic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Fujita T; Iida Y; Kaida T; Nabeta T; Ishii S; Maekawa E; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2017 Apr; 32(4):446-457. PubMed ID: 27672077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.
    Kristensen SL; Preiss D; Jhund PS; Squire I; Cardoso JS; Merkely B; Martinez F; Starling RC; Desai AS; Lefkowitz MP; Rizkala AR; Rouleau JL; Shi VC; Solomon SD; Swedberg K; Zile MR; McMurray JJ; Packer M;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
    Aguilar D; Bozkurt B; Ramasubbu K; Deswal A
    J Am Coll Cardiol; 2009 Jul; 54(5):422-8. PubMed ID: 19628117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics.
    McMurray JJV; DeMets DL; Inzucchi SE; Køber L; Kosiborod MN; Langkilde AM; Martinez FA; Bengtsson O; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD;
    Eur J Heart Fail; 2019 Nov; 21(11):1402-1411. PubMed ID: 31309699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.
    Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT
    JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glycemic control on in-hospital mortality among acute heart failure patients with reduced, mid-range, and preserved ejection fraction.
    Matsushita K; Harada K; Miyazaki T; Miyamoto T; Iida K; Tanimoto S; Yagawa M; Takei M; Nagatomo Y; Hosoda T; Yoshino H; Yamamoto T; Nagao K; Takayama M
    Heart Vessels; 2018 Sep; 33(9):1022-1028. PubMed ID: 29541844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus.
    Jang SY; Jang J; Yang DH; Cho HJ; Lim S; Jeon ES; Lee SE; Kim JJ; Kang SM; Baek SH; Cho MC; Choi DJ; Yoo BS; Kim KH; Park SK; Lee HY
    Cardiovasc Diabetol; 2021 Sep; 20(1):180. PubMed ID: 34496864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
    Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
    Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin A1c predicts heart failure hospitalization independent of baseline cardiac function or B-type natriuretic peptide level.
    Kishimoto I; Makino H; Ohata Y; Tamanaha T; Tochiya M; Kada A; Ishihara M; Anzai T; Shimizu W; Yasuda S; Ogawa H
    Diabetes Res Clin Pract; 2014 May; 104(2):257-65. PubMed ID: 24629410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
    Selvin E; Rawlings AM; Lutsey PL; Maruthur N; Pankow JS; Steffes M; Coresh J
    Circulation; 2015 Jul; 132(4):269-77. PubMed ID: 26022911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of Diabetes, Glycemic Control, and Risk of Heart Failure Among Adults With Diabetes: A Cohort Study.
    Yang HH; Li FR; Chen ZK; Zhou MG; Xie LF; Jin YY; Li ZH; Chen GC
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1166-1172. PubMed ID: 36383477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry.
    Targher G; Dauriz M; Tavazzi L; Temporelli PL; Lucci D; Urso R; Lecchi G; Bellanti G; Merlo M; Rossi A; Maggioni AP;
    Int J Cardiol; 2016 Jan; 203():587-93. PubMed ID: 26574932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry.
    Dauriz M; Targher G; Laroche C; Temporelli PL; Ferrari R; Anker S; Coats A; Filippatos G; Crespo-Leiro M; Mebazaa A; Piepoli MF; Maggioni AP; Tavazzi L;
    Diabetes Care; 2017 May; 40(5):671-678. PubMed ID: 28255009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.
    Gu J; Pan JA; Fan YQ; Zhang HL; Zhang JF; Wang CQ
    Cardiovasc Diabetol; 2018 Jun; 17(1):96. PubMed ID: 29960591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation.
    Lemesle G; Bonello L; de Labriolle A; Maluenda G; Syed AI; Collins SD; Ben-Dor I; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Jul; 104(1):41-5. PubMed ID: 19576319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreatic cancer patients with diabetes.
    Cheon YK; Koo JK; Lee YS; Lee TY; Shim CS
    Gut Liver; 2014 Mar; 8(2):205-14. PubMed ID: 24672663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of an inverse correlation between plasma B-type natriuretic peptide levels and insulin resistance on the diabetic condition in patients with heart failure.
    Inoue Y; Kawai M; Minai K; Ogawa K; Nagoshi T; Ogawa T; Yoshimura M
    Metabolism; 2016 Mar; 65(3):38-47. PubMed ID: 26892514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.